MRVL Stock Recent News

AI-driven Data Center has been the lone bright spot for Marvell, as the rest of the business has been hit hard by the cyclical semiconductor correction. I see some room for upside in the coming FQ2 report from strong demand for electro-optics and custom ASIC launches, but the non-data center businesses will be down meaningfully year-over-year. The company's focus on electro-optics and custom silicon positions it well for AI growth, with potential revenue growth of 15%-20% or higher over the next five years.

Marvell (MRVL) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

I.T. sector P/E recovers back near 30x, driven by optimism around AI trade. Marvell Technology is seen benefiting from AI in the years ahead, with the potential for AI to represent 40% of revenue by FY 2026. Marvell's valuation and earnings outlook remain uncertain, with a hold rating recommended for now.

While the long-term outlook for Marvell (MRVL) remains bright, the near-term challenges associated with export restrictions and the stock's high valuation warrant a more cautious approach.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Calgary, Alberta--(Newsfile Corp. - August 13, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to announce it has entered a collaboration with the FRAXA Research Foundation to test its lead asset MB204 in a preclinical model (FMR1) of Fragile X syndrome (FXS). Autism and FXS are closely related, often sharing clinical symptoms (e.g.

SANTA CLARA, Calif. , Aug. 5, 2024 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MRVL), a leader in infrastructure semiconductor solutions, today announced it will conduct a conference call following the release of its second quarter of fiscal year 2025 financial results on Thursday, August 29, 2024, at 1:45 p.m.

Marvell (MRVL) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

This bear call spread wins if MRVL drops, goes sideways or even if it jumps 15%.

New product line is the industry's first to integrate Arm® Neoverse® processors, inline compression, and four memory channels. Structera ™ A CXL near-memory accelerator family is optimized to address high-bandwidth memory applications such as deep learning and ML/AI on general-purpose servers.